176 related articles for article (PubMed ID: 2693029)
81. Clinical studies with gastric inhibitory polypeptide.
Brown JC; Otte S
World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
[TBL] [Abstract][Full Text] [Related]
82. On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans.
Asmar M; Tangaa W; Madsbad S; Hare K; Astrup A; Flint A; Bülow J; Holst JJ
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E614-21. PubMed ID: 19996386
[TBL] [Abstract][Full Text] [Related]
83. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
Heimbürger SMN; Hoe B; Nielsen CN; Bergmann NC; Hartmann B; Holst JJ; Vilsbøll T; Dejgaard TF; Christensen MB; Knop FK
Diabetologia; 2021 Nov; 64(11):2425-2431. PubMed ID: 34405256
[TBL] [Abstract][Full Text] [Related]
84. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
Meier JJ; Hücking K; Holst JJ; Deacon CF; Schmiegel WH; Nauck MA
Diabetes; 2001 Nov; 50(11):2497-504. PubMed ID: 11679427
[TBL] [Abstract][Full Text] [Related]
85. Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.
Mazzaferri EL; Starich GH; St Jeor ST
J Clin Endocrinol Metab; 1984 Apr; 58(4):640-5. PubMed ID: 6365944
[TBL] [Abstract][Full Text] [Related]
86. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
Ranganath LR; Beety JM; Morgan LM
Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
[TBL] [Abstract][Full Text] [Related]
87. Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.
Christensen M; Vedtofte L; Holst JJ; Vilsbøll T; Knop FK
Diabetes; 2011 Dec; 60(12):3103-9. PubMed ID: 21984584
[TBL] [Abstract][Full Text] [Related]
88. The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.
Chowdhury S; Wang S; Patterson BW; Reeds DN; Wice BM
Regul Pept; 2013 Nov; 187():42-50. PubMed ID: 24183983
[TBL] [Abstract][Full Text] [Related]
89. Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trial.
Heimburger SMN; Nielsen CN; Calanna S; Holst JJ; Vilsbøll T; Knop FK; Christensen MB
Diabetes Obes Metab; 2022 Jan; 24(1):142-147. PubMed ID: 34490741
[TBL] [Abstract][Full Text] [Related]
90. Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.
Wang S; Oestricker LZ; Wallendorf MJ; Sterl K; Dunai J; Kilpatrick CR; Patterson BW; Reeds DN; Wice BM
PLoS One; 2018; 13(2):e0192441. PubMed ID: 29466430
[TBL] [Abstract][Full Text] [Related]
91. Glucoregulation after canine islet transplantation: contribution of insulin secretory capacity, insulin action, and the entero-insular axis.
van der Burg MP; van Suylichem PT; Guicherit OR; Frölich M; Lemkes HH; Gooszen HG
Cell Transplant; 1997; 6(5):497-503. PubMed ID: 9331501
[TBL] [Abstract][Full Text] [Related]
92. Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients.
Skrha J; Hilgertová J; Jarolímková M; Kunešová M; Hill M
Physiol Res; 2010; 59(5):749-755. PubMed ID: 20406045
[TBL] [Abstract][Full Text] [Related]
93. Potential correlation between plasma total GIP levels and body mass index in Japanese patients with types 1 or 2 diabetes mellitus.
Kamoi K; Shinozaki Y; Furukawa K; Sasaki H
Endocr J; 2012; 59(4):353-63. PubMed ID: 22301939
[TBL] [Abstract][Full Text] [Related]
94. A glimpse of the 'natural history' of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis.
Coates PA; Ollerton RL; Luzio SD; Ismail I; Owens DR
Diabetes Res Clin Pract; 1994 Dec; 26(3):177-87. PubMed ID: 7736898
[TBL] [Abstract][Full Text] [Related]
95. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
Hinds A; Sheehan AG; Machida H; Parsons HG
Diabetes Res; 1991 Oct; 18(2):69-78. PubMed ID: 1841815
[TBL] [Abstract][Full Text] [Related]
96. Pleiotropic effects of GIP on islet function involve osteopontin.
Lyssenko V; Eliasson L; Kotova O; Pilgaard K; Wierup N; Salehi A; Wendt A; Jonsson A; De Marinis YZ; Berglund LM; Taneera J; Balhuizen A; Hansson O; Osmark P; Dunér P; Brøns C; Stancáková A; Kuusisto J; Bugliani M; Saxena R; Ahlqvist E; Kieffer TJ; Tuomi T; Isomaa B; Melander O; Sonestedt E; Orho-Melander M; Nilsson P; Bonetti S; Bonadonna R; Miccoli R; Delprato S; Marchetti P; Madsbad S; Poulsen P; Vaag A; Laakso M; Gomez MF; Groop L
Diabetes; 2011 Sep; 60(9):2424-33. PubMed ID: 21810601
[TBL] [Abstract][Full Text] [Related]
97. No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects.
Nauck MA; Holle H; Kahle M; Tytko A; Deacon CF; Holst JJ; Meier JJ
Peptides; 2020 Mar; 125():170176. PubMed ID: 31669136
[TBL] [Abstract][Full Text] [Related]
98. Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting type 2 diabetes.
Hovorka R; Albarrak A; Chassin L; Luzio SD; Playle R; Owens DR
Diabet Med; 2001 Oct; 18(10):797-802. PubMed ID: 11678969
[TBL] [Abstract][Full Text] [Related]
99. Effect of source of dietary fats on serum glucose, insulin, and gastric inhibitory polypeptide responses to mixed test meals in subjects with non-insulin dependent diabetes mellitus.
Lardinois CK; Starich GH; Mazzaferri EL; DeLett A
J Am Coll Nutr; 1988 Apr; 7(2):129-36. PubMed ID: 3283195
[TBL] [Abstract][Full Text] [Related]
100. Effect of glucose-dependent insulinotropic polypeptide on whole-body glucose utilization in sheep.
Rose MT; Itoh F; Takahashi Y
Exp Physiol; 1998 Nov; 83(6):783-92. PubMed ID: 9782188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
